rufloxacin has been researched along with imipenem, anhydrous in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gomez-Lus, ML; Herrera, I; Martin, M; Martinez, P; Perez, P; Prieto, J | 1 |
1 other study(ies) available for rufloxacin and imipenem, anhydrous
| Article | Year |
|---|---|
Rufloxacin enhances susceptibility of Escherichia coli to leukocyte activity.
Topics: Anti-Infective Agents; Blood Bactericidal Activity; Escherichia coli; Fluoroquinolones; Humans; Imipenem; Quinolones | 1995 |